Kenvue Inc. (NYSE:KVUE – Get Free Report) has earned a consensus rating of “Hold” from the thirteen analysts that are covering the company, MarketBeat.com reports.One analyst has rated the ...

In this article, we are going to take a look at where Kenvue Inc. (NYSE:KVUE) stands against the other stocks Jim Cramer discussed. In a recent appearance on CNBC’s Squawk on the Street ...

AUSTIN, Texas — Editor's note: This blog is no longer being updated. Click here for the latest on the local weather conditions. On Wednesday evening, a few surprise showers and thunderstorms ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Kenvue (KVUE) will share new clinical data demonstrating how its brands are leveraging the latest science to shape the future of the Skin Health & Beauty category at the 2025 American Academy of ...

In light of that, when we looked at Kenvue (NYSE:KVUE) and its ROCE trend, we weren't exactly thrilled. If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit ...

Kenvue (KVUE) has settled its proxy fight with activist Starboard value, CNBC’s David Faber reports, citing sources. See what stocks are receiving Strong Buy ratings from top-rated analysts.

March 5 (Reuters) - Consumer health company Kenvue (KVUE.N), opens new tab said on Wednesday it had appointed three new directors to its board as part of an agreement with activist investor ...

In recent trading, shares of Kenvue Inc (Symbol: KVUE) have crossed above the average analyst 12-month target price of $23.23, changing hands for $23.60/share. When a stock reaches the target an ...

Below is Validea's guru fundamental report for KENVUE INC (KVUE). Of the 22 guru strategies we follow, KVUE rates highest using our Multi-Factor Investor model based on the published strategy of ...